Document is current
Any future updates will be listed below
-
Authors
Martinez Arias, Alfonso https://orcid.org/0000-0002-1781-564X
Rivron, Nicolas https://orcid.org/0000-0003-1590-5964
Moris, Naomi https://orcid.org/0000-0003-1910-5454
Tam, Patrick https://orcid.org/0000-0001-6950-8388
Alev, Cantas https://orcid.org/0000-0002-4879-8782
Fu, Jianping https://orcid.org/0000-0001-9629-6739
Hadjantonakis, Anna-Katerina https://orcid.org/0000-0002-7580-5124
Hanna, Jacob H. https://orcid.org/0000-0003-2042-9974
Minchiotti, Gabriella https://orcid.org/0000-0003-0225-9043
Pourquie, Olivier https://orcid.org/0000-0001-5189-1227
Sheng, Guojun https://orcid.org/0000-0001-6759-3785
Solnica Krezel, Liliana https://orcid.org/0000-0003-0983-221X
Veenvliet, Jesse V.
Warmflash, Aryeh
- License Information
-
More Information
Article History
First Online: 2 September 2024
Competing interests
: A.M.A. and N.M. are inventors on the patent Human Polarised Three-Dimensional Cellular Aggregates PCT/GB2019/052670. A.W. is a cofounder of and holds equity in Simbryo Technologies. N.R. is an inventor on the patents ‘Blastoid, cell line based artificial blastocyst’ (EP2986711) and ‘Blastocyst-like cell aggregate and methods’ (EP21151455.9), which are both licensed to dawn-bio, a company he co-founded. J.F. has filed patents or patent applications describing devices and methods for the development of human embryo models (U.S. Patent Application numbers 63/553,448, US2020049721, US20190321415 and WO2018106997). J.H.H. was granted (through the Yeda–Weizmann Institute of Science) patents relevant to the findings and technologies discussed here (naive and naive-like pluripotency and mouse and human structure-complete embryo models), and is a co-founder and chief scientific advisor of Renewal Bio, which has licensed technologies mentioned above. J.V.V. declares that part of the work in his laboratory is funded by an EIC Pathfinder grant (Horizon-EIC-2021-PathfinderChallenges-01 101071203, SUMO), which includes support of ELSA activities. The remaining authors declare no competing interests.
